Celer Soluciones

< Back
IBM-Pfizer-monitorización-pacientes-ensayos-clínicos

IBM and Pfizer revolutionize patient monitoring in clinical trials

Drug company Pfizer and tech firm IBM are working together on an innovative wearable device system to enable real-time patient monitoring. This system could lead to a radical change in how clinical trials are conducted.

Patients’ progress can be more closely controlled thanks to this technology. This means medical staff can apply their knowledge 100% reliably, detecting any alterations or contraindications on a personalized level for each patient.

Mobile technology at the service of clinical trials

The project Pfizer and IBM have embarked on in the US initially focuses on patients with Parkinson’s disease.

The speed with which this disease develops means constant changes in medication and treatment are necessary. For this reason it is highly useful to be able to continuously monitor a patient’s symptoms and their evolution for medical control to be fully effective

This project seeks to obtain a wider view, which is currently very limited, of patient monitoring, with the use wearable devices which monitor a patient’s condition in real time and send relevant data back to the medical professionals, thereby revolutionizing the conventional conduct of clinical trials.

Both companies will work jointly over several years in order to develop a truly effective system, determining which information needs to be collected and which devices are suitable for reproducing data from a truly useful, accurate and objective flow, for clinical trial personnel.

The future: personalized treatments wherever the patient is

With the introduction of mobile technology in clinical trials, real-time data can be obtained wherever the patient is and at any time. This will enable each individual’s treatment to be personalized much faster, more reliably and more efficiently and in sync with the evolution of the disease, thanks to analysis of the information collected.

The goal for the future is for any patient in the world to be able to benefit from mobile technology in order to get the best treatment for their condition. This will lead to a worldwide improvement in the healthcare system, enabling far more personalized and controlled treatments to be established.

The use of new technology in the medical sector will break down barriers. We are faced with an increasingly global sector in which professionals and patients from anywhere in the world can communicate and interact with each other. This fact makes specialized translation of medical correspondence and documents increasingly important, thereby ensuring that any patient can benefit from medical breakthroughs wherever they are or whatever language they speak.